Showing 561 - 580 results of 2,482 for search '"hepatitis"', query time: 0.06s Refine Results
  1. 561

    Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic by A. Jewett, A. A. Al-Tayyib, L. Ginnett, B. D. Smith

    Published 2013-01-01
    “…The Centers for Disease Control and Prevention (CDC) recommends testing and linkage to care for persons most likely infected with hepatitis C virus (HCV), including persons with human immunodeficiency virus. …”
    Get full text
    Article
  2. 562
  3. 563

    Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro by Ting Li, Ting Fang, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Xiaochen Yu, Bei Sun, Liming Chen

    Published 2021-01-01
    “…Background: Metabolic associated fatty liver disease (MAFLD), characterized by hepatic lipid accumulation and fatty degeneration, is intertwined with obesity and type 2 diabetes mellitus (T2DM). …”
    Get full text
    Article
  4. 564
  5. 565

    Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection by Kojiro Michitaka, Atsushi Hiraoka, Yoshio Tokumoto, Keiko Ninomiya, Tomoyuki Ninomiya, Norio Horiike, Masanori Abe, Yoichi Hiasa

    Published 2014-01-01
    “…Information regarding the progression of acute hepatitis B virus (HBV) infection to chronic infection in adults is scarce. …”
    Get full text
    Article
  6. 566

    Acute Sickle Hepatic Crisis after Liver Transplantation in a Patient with Hb SC Disease by J. H. Gillis, S. K. Satapathy, L. Parsa, P. B. Sylvestre, N. Dbouk

    Published 2015-01-01
    “…Acute sickle hepatic crisis (ASHC) has been observed in approximately 10% of patients with sickle cell disease. …”
    Get full text
    Article
  7. 567

    Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment by Shihui Li, Xu Zheng, Hui Li, Jun Zheng, Xiaolong Chen, Wei Liu, Yan Tai, Yingcai Zhang, Genshu Wang, Yang Yang

    Published 2018-01-01
    “…In the present study, we examined the impact of MSCs on hepatic inflammatory response such as neutrophil influx and liver damage in a rat model of 70% hepatic IRI. …”
    Get full text
    Article
  8. 568

    Canadian Hepatitis C Look-Back Investigation to Detect Transmission from an Infected General Surgeon by Meenakshi Dawar, Tammy L Stuart, Lamont E Sweet, Anne M Neatby, Lewis P Abbott, Anton P Andonov, Tom Wong, Robert Gervais, Rob Stirling

    Published 2010-01-01
    “…BACKGROUND: In February 2007, a general surgeon in Charlottetown, Prince Edward Island, tested positive for hepatitis C virus (HCV). The surgeon’s infection onset date could not be determined; however, episodic hepatic enzyme elevations were first detected in November 2004 and again in February 2007. …”
    Get full text
    Article
  9. 569

    Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China by Chengguang Hu, Guosheng Yuan, Junwei Liu, Huaping Huang, Yanyu Ren, Yinping Li, Xuefu Chen, Wei Li, Tao Wu, Hong Deng, Yanzhong Peng, Yong-Yuan Zhang, Yuanping Zhou

    Published 2018-01-01
    “…There is scarcity of data in literature regarding the treatment response to sofosbuvir- (SOF-) based therapies in Chinese patients with chronic Hepatitis C Virus (HCV) infection. The aim of this study was to evaluate the efficacy and safety of SOF-based regimens for chronic hepatitis C (CHC) patients without cirrhosis in a real-world setting in mainland China. …”
    Get full text
    Article
  10. 570
  11. 571

    Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes by Theresa Liu, Glen T Howell, Lucy Turner, Kimberley Corace, Gary Garber, Curtis Cooper

    Published 2014-01-01
    “…BACKGROUND: Marijuana smoking is prevalent among hepatitis C virus-infected patients. The literature assessing the influence of marijuana on liver disease progression and hepatitis C virus antiviral treatment outcomes is conflicting.…”
    Get full text
    Article
  12. 572

    Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy by Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar

    Published 2015-01-01
    “…Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy. …”
    Get full text
    Article
  13. 573

    Concurrent Hepatic Artery and Portal Vein Thrombosis after Orthotopic Liver Transplantation with Preserved Allografts by Arshad Khan, P. Park, Jose Oberholzer, Ivo Tzvetanov, Raquel Garcia Roca, Ron C. Gaba, Enrico Benedetti, Hoonbae Jeon

    Published 2014-01-01
    “…In fact, hepatopetal arterial and portal venous neovascularization are known albeit obscure phenomena that can preserve posttransplant hepatic function under the extenuating circumstances of complete interruption of blood flow to the graft. …”
    Get full text
    Article
  14. 574
  15. 575

    A note for the global stability of a delay differential equation of hepatitis B virus infection by Bao-Zhu Guo, Li-Ming Cai

    Published 2011-05-01
    “…Kuang and J.D.Nagy,Dynamics of a delay differential equation model of hepatitis B virus infection, Journal of Biological Dynamics, 2(2008), 140-153].…”
    Get full text
    Article
  16. 576
  17. 577

    Dynamical Behavior of Stochastic Markov Switching Hepatitis B Epidemic Model with Saturated Incidence Rate by Chun Lu

    Published 2022-01-01
    “…The article researches a stochastic hepatitis B epidemic model with saturated incidence rate, which is perturbed by both white noise and colored noise. …”
    Get full text
    Article
  18. 578

    Serological Evidence of Hepatitis B and E and Dengue Coinfection in Chadian Patients and Impact on Lipidemia Profile by Alexandre Kanga Djasrabe, Borris Rosnay Tietcheu Galani, Moussa Mahamat Ali, Fissou Henry Yandai, Bessimbaye Nadlaou, Mayann Habkreo, Nicolas Yanou Njintang

    Published 2022-01-01
    “…Objective. Viral hepatitis is an endemic disease in Chad. However, few studies have documented coinfection cases and their impact on cardiovascular risk. …”
    Get full text
    Article
  19. 579

    Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city by Muhannad Abdullah Alazzawy

    Published 2018-07-01
    “…A cross sectional study was conducted in Kirkuk city from June 2017 to March 2018. The number of hepatitis patient understudy were 62 hepatitis C (27 acute and 35 chronic) whose ages were between 20-75 years old. …”
    Get full text
    Article
  20. 580

    Renovascular Mistaken as Essential Hypertension due to Giant Hepatic Hydatid: A Rare Treatable Entity by Awaji Qasim Alnami, Liaqat Ali Khan, Said Samir Qeshta, Abdulrahman Alnami, Akram Awad, Waleed Mohalwi, Musa Tumaihi

    Published 2018-01-01
    “…We report a case of giant hepatic hydatid cyst with the possibility of renovascular hypertension due to mass effect as evident by dramatic drop of the blood pressure to its normotensive state postoperatively.…”
    Get full text
    Article